Evidence map›Paper›PMID 36409086›Full record

ArticlemBio2022

Large-Scale CRISPRi and Transcriptomics of Staphylococcus epidermidis Identify Genetic Factors Implicated in Lifestyle Versatility.

Michelle Spoto, Johanna P Riera Puma, Elizabeth Fleming, Changhui Guan, Yvette Ondouah Nzutchi, Dean Kim, Julia Oh

Abstract read
In one paragraph

Article in mBio, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Beneficial perspective onFrontiers in immunology · 2025
    Review
  5. Review
  6. Review
  7. Review
  8. Article
  9. Review
  10. Article
  11. The impact of oxygen content onFrontiers in microbiology · 2024
    Article
  12. Genome-wide transcription response ofFrontiers in microbiology · 2024
    Article
  13. Competition-cooperation mechanism betweenFrontiers in microbiology · 2023
    Article
  14. Review
  15. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Michelle SpotoThe Jackson Laboratory for Genomic Medicine, Farmington, Connecticut, USA.
Johanna P Riera PumaThe Jackson Laboratory for Genomic Medicine, Farmington, Connecticut, USA.
Elizabeth FlemingThe Jackson Laboratory for Genomic Medicine, Farmington, Connecticut, USA.
Changhui GuanThe Jackson Laboratory for Genomic Medicine, Farmington, Connecticut, USA.
Yvette Ondouah NzutchiThe Jackson Laboratory for Genomic Medicine, Farmington, Connecticut, USA.
Dean KimThe Jackson Laboratory for Genomic Medicine, Farmington, Connecticut, USA.
Julia OhThe Jackson Laboratory for Genomic Medicine, Farmington, Connecticut, USA.ORCID 0000-0002-5534-7023

Funding

Shared Resource ManagementP30CA034196 · NCI · JACKSON LABORATORY · PI Mark D ADAMS · 1985 to 2026
$61.9M
Technology Development Project - Increasing the complexity of ex vivo human airway models for studying immune response to viral infectionU19AI142733 · NIAID · JACKSON LABORATORY · PI Adolfo Garcia-Sastre, Anna Karolina Palucka · 2019 to 2026
$23.1M
Topological Mapping of Immune, Microbiota, Metabolomic and Clinical Phenotypes to Reveal ME/CFS Disease Mechanisms - Clinical Research ProjectU54NS105539 · NINDS · JACKSON LABORATORY · PI VERNON, SUZANNE D · 2017 to 2022
$10.6M
Metagenomes to Therapeutics: Defining the Rules for Engineering the Skin MicrobiomeDP2GM126893 · NIGMS · JACKSON LABORATORY · PI OH, JULIA · 2017 to 2017
$2.8M
Molecular Mechanisms of Staphylococcus Epidermidis Strain DiversityR01AR078634 · NIAMS · JACKSON LABORATORY · PI OH, JULIA · 2021 to 2025
$2.5M
Skeletal, Craniofacial and Oral Biology Training GrantR90DE022526 · NIDCR · UNIVERSITY OF CONNECTICUT SCH OF MED/DNT · PI MINA, MINA · 2011 to 2022
$627k
Skin Microbiome of Monogenic Skin DisordersR21AR075174 · NIAMS · JACKSON LABORATORY · PI OH, JULIA · 2019 to 2022
$466k
Community organizing: Harnessing the interactions of the microbiome as a basis for novel therapeutic strategiesK22AI119231 · NIAID · JACKSON LABORATORY · PI OH, JULIA · 2016 to 2017
$270k
Bioengineered skin microbiota for cutaneous mitigation of Netherton SyndromeR43AR073562 · NIAMS · AZITRA, INC. · PI OH, JULIA, WHITFILL, TRAVIS · 2018 to 2018
$225k
Molecular Mechanisms Underlying Transition to Virulence in Staphylococcus epidermidisF30DE027870 · NIDCR · UNIVERSITY OF CONNECTICUT SCH OF MED/DNT · PI SPOTO, MICHELLE · 2018 to 2021
$180k
NCI NIH HHS P30 CA034196NIAID NIH HHS K22 AI119231NIAID NIH HHS U19 AI142733NIAMS NIH HHS R01 AR078634NIAMS NIH HHS R21 AR075174NIAMS NIH HHS R43 AR073562NIDCR NIH HHS F30 DE027870NIDCR NIH HHS R90 DE022526NIGMS NIH HHS DP2 GM126893NINDS NIH HHS U54 NS105539
6 · The paper itself

Abstract

Staphylococcus epidermidis is a ubiquitous human commensal skin bacterium that is also one of the most prevalent nosocomial pathogens. The genetic factors underlying this remarkable lifestyle plasticity are incompletely understood, mainly due to the difficulties of genetic manipulation, precluding high-throughput functional profiling of this species. To probe the versatility of S. epidermidis to survive across a diversity of environmental conditions, we developed a large-scale CRISPR interference (CRISPRi) screen complemented by transcriptional profiling (RNA sequencing) across 24 diverse conditions and piloted a droplet-based CRISPRi approach to enhance throughput and sensitivity. We identified putative essential genes, importantly revealing amino acid metabolism as crucial to survival across diverse environments, and demonstrated the importance of trace metal uptake for survival under multiple stress conditions. We identified pathways significantly enriched and repressed across our range of stress and nutrient-limited conditions, demonstrating the considerable plasticity of S. epidermidis in responding to environmental stressors. Additionally, we postulate a mechanism by which nitrogen metabolism is linked to lifestyle versatility in response to hyperosmotic challenges, such as those encountered on human skin. Finally, we examined the survival of S. epidermidis under acid stress and hypothesize a role for cell wall modification as a vital component of the survival response under acidic conditions. Taken together, this study integrates large-scale CRISPRi and transcriptomics data across multiple environments to provide insights into a keystone member of the human skin microbiome. Our results additionally provide a valuable benchmarking analysis for CRISPRi screens and are a rich resource for other staphylococcal researchers.

Indexed as

Staphylococcal InfectionsClustered Regularly Interspaced Short Palindromic RepeatsHumansSkinStaphylococcus epidermidisTranscriptomeCRISPR-Cas9CRISPRilarge-scale knockdownStaphylococcus epidermidistranscriptomics

Identifiers

PMID36409086
PMCPMC9765180

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.